Información:
Error:
ID
34306
Descripción
Vitamin D Supplementation for Treatment of Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01230307
Link
https://clinicaltrials.gov/show/NCT01230307
Palabras clave
Versiones (1)
- 16/1/19 16/1/19 -
Titular de derechos de autor
GSK group of companies
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Heart Failure NCT01230307
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
hf patients with lv systolic dysfunction of ischemic or non-ischemic origin and an lvef <40% using nuclear ventriculography or echocardiography within the last 6 months.
boolean
ID.2
Item
attempts should have been made at optimizing medical therapy and the participant should be stable on these medications for at least 3 months.
boolean
ID.3
Item
patients with a 25(oh)d level between 10-25 ng/ml
boolean
ID.4
Item
inability to give informed consent
boolean
ID.5
Item
patients with sarcoidosis or other granulomatous disease that can alter vitamin d metabolism
boolean
ID.6
Item
patients with primary valvular hf, hypertrophic cardiomyopathy, and drug-induced hf
boolean
ID.7
Item
renal dysfunction defined as serum creatinine > 2.5 mg/dl
boolean
ID.8
Item
pregnant women
boolean
ID.9
Item
patients <18 years of age
boolean
ID.10
Item
patients on vitamin d supplementation
boolean